Health Europa: Cannabis, women’s health, and pelvic conditions

Published in Health Europa on July 4th, 2019. Discover how Columbia Care are developing products to meet an unmet clinical need in women suffering from pelvic conditions. As one of the nation’s most experienced producers of medical cannabis products, Columbia Care is committed to helping patients suffering from a wide range of state permitted qualifying conditions, including Read More

Columbia Care Announces Statewide Launch in Florida, the Fastest Growing US Medical Cannabis Market, with Grand Opening of First Dispensary

Global Medical cannabis leader expands dispensary footprint to Gainesville, one of Florida’s most densely populated metropolitan areas and provides update on new cultivation and manufacturing facility Gainesville dispensary to provide differentiated product offering with portfolio of proprietary, GMP manufactured pharmaceutical-quality products and provider-based care and educational model designed to deliver optimal patient journey and experience Read More

Yahoo Finance: Medicare-for-all could ‘dramatically’ increase access to medical cannabis

Published in Yahoo! News on July 1st, 2019. Key Democrats have been talking up Medicare-for-all in the presidential race, and Nicholas Vita, the CEO of cannabis company Columbia Care, says a move to that type of health care system could benefit medical cannabis too. He spoke to Yahoo Finance’s Brian Sozzi and Akiko Fujita.

Columbia Care Enters World’s Largest Regulated Cannabis Market with Grand Opening of Flagship Dispensary in San Diego, California

Global medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan market Nationally proven high-touch, provider-based dispensary model and proprietary pharmaceutical-quality products bring novel, impactful and personalized cannabis-based health and wellness solutions to California NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW, OTC: COLXF), one of Read More

Columbia Care Announces Launch of Pioneering Research Study to Identify Genetic Factors Affecting the Efficacy and Safety of Medical Cannabis

First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to support optimal product dosing and formulation selection NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO: CCHW, OTC: COLXF), one of the largest global operators in the medical cannabis industry, with licenses Read More

A Cannabis Credit Card? Yeah, That’s a Real Thing Now

Published on The Motley Fool by Sean Williams on June 16th, 2019. Few industries are currently garnering as much attention on Wall Street as legal marijuana — and for good reason. After the industry generated $12.2 billion in legal worldwide sales in 2018, the duo of Arcview Market Research and BDS Analytics have called for Read More

Marijuana dispensary rolls out its own credit card as weed industry works to go beyond cash-only sales

Published in Chicago Tribune on June 14th, 2019. Marijuana company Columbia Care is rolling out a credit card for customers to use at its dispensaries, creating a new payment option for a clientele that has largely had to deal in cash. Like banks, credit card companies hesitate to get involved in the cannabis industry because the Read More

Columbia Care Announces National Launch of the CNC Card – the Nation’s First Cannabis Industry Credit Card

Currently available in multiple markets, the CNC card will enable cannabis consumers and dispensaries nationwide to transact electronically using credit in all of Columbia Care’s markets by the end of 2019 First legal, transparent and highly scalable credit card solution available to fast-growing $23B US cannabis industry. Successful pilot program in New York has average Read More

Columbia Care and Westmed Announce Initiation of a Research Study on the Safety and Efficacy of Precisely Formulated Cannabis-Based Medicines in Rheumatologic Patients

IRB-approved collaboration initiated to demonstrate clinical value of Columbia Care’s precisely formulated, pharmaceutical-quality cannabis-based medicine, ClaraCeed™, through rigorous scientific research with leading medical practice in significant, underserved patient population NEW YORK & PURCHASE, N.Y.–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), one of the largest multi-state operators in the medical cannabis industry, with Read More

Columbia Care Releases Preliminary Results for First Quarter 2019 and Full Year 2018

Organic growth continues to drive revenue increases of 45% for Q1 2019 and 35% for FY 2018 on year-over-year basis Closing of go-public transaction to accelerate strategy execution and long-term growth prospects NEW YORK–(BUSINESS WIRE)– Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), today announced preliminary revenue and gross profit results for the Read More